Search - tctmd.com

Displaying 221 - 240 of 778

Sort: Relevancy | Date

News Daily News

Short-term Outcomes Worse After Failed CTO PCI

December 10, 2014

News Daily News

Postapproval Study Confirms Safety, Efficacy of Transcatheter Pulmonary Valve in Real World

December 04, 2014

News Industry News

Shockwave Medical Announces Positive Late Breaking Results of Study of Novel Lithoplasty System for the Treatment of Peripheral Artery Disease

November 04, 2014

News Industry News

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

November 03, 2014

News Features TCT 2014

Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease

October 31, 2014

News Daily News

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

October 24, 2014

News Daily News

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

October 24, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

October 24, 2014

News Daily News

药物洗脱球囊治疗重症下肢缺血患者的膝下病变失败

October 10, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

News Daily News

Los Balones liberadores de Fármacos Fracasan en el Manejo de Lesiones por Debajo de la Rodilla en Pacientes con Isquemia Crítica de las Extremidades

October 10, 2014

News Daily News

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

October 10, 2014

DEB vs Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in CLI

Presentation

DEB vs Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in CLI

Presenter: T. Zeller

October 08, 2014

News Daily News

ACC Backs Off Stance Against Complete Revascularization

October 03, 2014

News Conference News TCT 2014

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

September 18, 2014

Sirolimus-Eluting Balloon Angioplasty Dilatation System for ISR Indication: The SABRE Trial

Presentation TCT 2014

Sirolimus-Eluting Balloon Angioplasty Dilatation System for ISR Indication: The SABRE Trial

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Stefan Verheye

September 16, 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presentation TCT 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Eric J. Dippel

September 16, 2014

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

Presentation TCT 2014

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

Presenter: Carlo Di Mario

September 16, 2014

Gender-related Differences in 30-day Mortality Among Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Angioplasty

Presentation TCT 2014

Gender-related Differences in 30-day Mortality Among Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Angioplasty

Presenter: Francesco Tomassini

September 16, 2014

Femoral Approach with Systematic Use of FemoSeal? Closure Device Compared to Radial Approach in Primary Angioplasty: a Propensity-matched Comparison

Presentation TCT 2014

Femoral Approach with Systematic Use of FemoSeal? Closure Device Compared to Radial Approach in Primary Angioplasty: a Propensity-matched Comparison

Presenter: Stefano Rigattieri

September 16, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.